Anzeige
Mehr »
Login
Samstag, 26.09.2020 Börsentäglich über 12.000 News von 645 internationalen Medien
Monsterhochzeit - Die 200 Mio. USD News! Kursexplosion am Montag!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrImplant system maker Spinal Elements files for $100M Nasdaq IPO
FrGalecto bags $64M to push lung fibrosis med toward EU nod
FrUnited Airlines to offer COVID-19 testing, starting from SFO to Hawaii
FrPalladio bags $20M to take once-discarded drug through phase 3
FrNew atlas of the human heart could guide personalized medicine in cardiology
FrNovavax kick-starts phase 3 of COVID-19 vaccine in U.K. as cases surge across the country
FrFlagship's Valo emerges with $100M and plans to transform R&D
FrChutes & Ladders-Day One brings on Gilead alum Bender as CEO
FrLooking for an edge in the wet AMD market, phase 3 biotech Opthea guns for $150M IPO
DoBabson Diagnostics nets new CEO, plus $13.7M for its blood test devices
DoNovo Nordisk tees up phase 3 trial for once-weekly insulin
DoFDA greenlights its first coronavirus antibody blood test for the point of care
DoLumen bags U.S. grant for GI-focused COVID-19 antibody cocktail
DoPoxel posts phase 3 diabetes data ahead of approval decision
DoAgios helps identify genes that allow cancer to escape the immune system
DoModerna's COVID-19 vaccine investigator leaves FDA advisory committee over conflict of interest
DoCTI Clinical Trial snaps up Clinart to boost its Middle East, North Africa reach
DoVersant's Monte Rosa reels in $96M to bankroll 'molecular glue' treatments for cancer, other diseases
MiLabCorp to roll out Resolution Bio's lung cancer liquid biopsy test
MiSilverback Therapeutics nets $85M top-up to push lead ADC through phase 1
MiCognoa's AI-powered diagnostic app for autism clears clinical study, heads for FDA review
MiFDA to set high bar for emergency COVID-19 vaccine approvals
MiRoche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved
MiJ&J starts COVID-19 vaccine phase 3, eyes early 2021 approval
MiNew insights into the coronavirus spike protein could inspire vaccine development